Close

LumiraDx Partners with British In Vitro Diagnostics Association to Report on the Role of Rapid Diagnostics in Tackling Antimicrobial Resistance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 1/27/2023

1. INTC
2. TSLA
3. SPY
4. V
5. LCID
6. HAS
7. CVX
8. MA
9. AXP
10. FE


Go back to LumiraDx Partners with British In Vitro Diagnostics Association to Report on the Role of Rapid Diagnostics in Tackling Antimicrobial Resistance
(NASDAQ: LMDX) Delayed: 0.91 +0.03 (3.41%)
Previous Close $0.88    52 Week High $ 
Open $0.91    52 Week Low $ 
Day High $0.91    P/E N/A 
Day Low $0.87    EPS $ 
Volume 94,502       

(NASDAQ: LMDX) Delayed: 0.91 +0.03 (3.41%)
Previous Close $0.88    52 Week High $ 
Open $0.91    52 Week Low $ 
Day High $0.91    P/E N/A 
Day Low $0.87    EPS $ 
Volume 94,502